Avanos Medical (AVNS) Non-Current Assets (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Non-Current Assets data on file, last reported at $725.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 4.01% year-over-year to $725.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.8 billion (down 26.8% YoY), and the FY2025 full-year result was $718.3 million, down 5.59% from the prior year.
• Non-Current Assets climbed to $725.1 million in Q1 2026, from $718.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.3 billion in Q1 2022 to a low of $683.0 million in Q2 2025.
• A 5-year average of $1.1 billion and a median of $1.2 billion in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets rose 10.53% in 2022 and slumped 42.3% in 2025, its largest moves.
• Tracing AVNS's Non-Current Assets over 5 years: stood at $1.2 billion in 2022, then advanced by 3.66% to $1.2 billion in 2023, then sank by 36.88% to $760.8 million in 2024, then fell by 5.59% to $718.3 million in 2025, then climbed by 0.95% to $725.1 million in 2026.
• Business Quant data shows AVNS's Non-Current Assets at $725.1 million in Q1 2026, $718.3 million in Q4 2025, and $716.3 million in Q3 2025.